Application Nr Approved Date Route Status External Links
ANDA202095 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Roweepra Xr Is Indicated As Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients 12 Years Of Age And Older With Epilepsy. Roweepra Xr Is Indicated For Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Patients 12 Years Of Age And Older With Epilepsy ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments